Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Oct 27, 2024; 16(10): 3078-3083
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3078
Single incision laparoscopic surgery for hepatocellular carcinoma
Ilhan Karabicak, Kadir Yildirim, Mahmut Fikret Gursel, Zafer Malazgirt
Ilhan Karabicak, Kadir Yildirim, Mahmut Fikret Gursel, Zafer Malazgirt, Department of General Surgery, Samsun VM Medicalpark Hospital, Samsun 55200, Türkiye
Author contributions: Karabicak I and Yildirim K designed the overall concept, design of the manuscript and contributed to the writing; Gursel MF and Malazgirt Z contributed to the manuscript and editing the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Ilhan Karabicak, MD, Associate Professor, Department of General Surgery, Samsun VM Medicalpark Hospital, Mimar Sinan Mahallesi Alparslan Bulvarı No. 17 Atakum, Samsun 55200, Türkiye. ikarabicak@yahoo.com
Received: March 14, 2024
Revised: June 14, 2024
Accepted: July 15, 2024
Published online: October 27, 2024
Processing time: 197 Days and 16.5 Hours
Core Tip

Core Tip: Single incision laparoscopic liver resection (SILLR) is the most recent development in the laparoscopic approach to the liver. SILLR is accepted less invasive than multiport LLR (MPLLR). SILLR became favorable among surgeons and patients with reduced pain and superior cosmetic appearance for benign liver tumors and in metastatic liver tumors while not compromising patient safety and oncologic principles. SILLR did not become as popular as MPLLR since most of hepatocellular carcinoma patients have an underlying chronic liver disease. One of the concerns is if SILLR would reduce the surgical margin because of the limited exposure and difficulty of procedure itself. However, large case series showed that all the patients had R0 resection even wider surgical margin.